184 related articles for article (PubMed ID: 3875717)
1. Clinical features, autoantibodies and HLA-DR antigens in rheumatoid arthritis.
Walton K; Dyer PA; Grennan DM; Haeney M; Harris R
J Rheumatol; 1985 Apr; 12(2):223-6. PubMed ID: 3875717
[TBL] [Abstract][Full Text] [Related]
2. Adult seronegative arthritis with antinuclear antibodies: a distinct group of patients with a different immunogenetic pattern from seropositive rheumatoid arthritis and a good outcome.
Saudan-Kister A; Gabay C; Tiercy JM; Mermillod B; Guerne PA; Vischer TL
Rev Rhum Engl Ed; 1996 May; 63(5):313-20. PubMed ID: 8789876
[TBL] [Abstract][Full Text] [Related]
3. [HLA-DR in rheumatoid arthritis].
Iakovleva DB; Benevolenskaia LI; Orlov-Morozov AV; Kalinina NM
Ter Arkh; 1985; 57(8):80-2. PubMed ID: 3934781
[TBL] [Abstract][Full Text] [Related]
4. Increased frequency of Gm(1,2;21) phenotype in HLA-DR4 positive seropositive rheumatoid arthritis.
Zarnowski H; Mierau R; Werdier D; Antons M; Genth E; Hartl PW
J Rheumatol; 1986 Oct; 13(5):858-63. PubMed ID: 3493344
[TBL] [Abstract][Full Text] [Related]
5. HLA-DR1, DR4, and DRB1 disease related subtypes in rheumatoid arthritis. Association with susceptibility but not severity in a city wide community based study.
Suarez-Almazor ME; Tao S; Moustarah F; Russell AS; Maksymowych W
J Rheumatol; 1995 Nov; 22(11):2027-33. PubMed ID: 8596139
[TBL] [Abstract][Full Text] [Related]
6. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles.
Irigoyen P; Lee AT; Wener MH; Li W; Kern M; Batliwalla F; Lum RF; Massarotti E; Weisman M; Bombardier C; Remmers EF; Kastner DL; Seldin MF; Criswell LA; Gregersen PK
Arthritis Rheum; 2005 Dec; 52(12):3813-8. PubMed ID: 16320316
[TBL] [Abstract][Full Text] [Related]
7. Study of autoantibodies, natural antibodies and IgE level in four families with rheumatoid arthritis.
Merétey K; Gömör B; Görgényi F; Gyódy E; Petrányi GG
Z Rheumatol; 1987; 46(4):189-95. PubMed ID: 3499721
[TBL] [Abstract][Full Text] [Related]
8. HLA-DR4 antigen and IgM rheumatoid factors.
Queirós MV; Sancho MR; Caetano JM
J Rheumatol; 1982; 9(3):370-3. PubMed ID: 6981703
[TBL] [Abstract][Full Text] [Related]
9. HLA and rheumatoid arthritis: susceptibility or severity?
Jaraquemada D; Ollier W; Awad J; Young A; Festenstein H
Dis Markers; 1986 Jun; 4(1-2):43-53. PubMed ID: 3482987
[TBL] [Abstract][Full Text] [Related]
10. Rheumatoid factors and HLA-DR4 in RA.
Emery P; Panayi GS; Welsh KI; Cole BC
J Rheumatol; 1985 Apr; 12(2):217-22. PubMed ID: 3875716
[TBL] [Abstract][Full Text] [Related]
11. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ
Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452
[TBL] [Abstract][Full Text] [Related]
12. An immunogenetic study of older age onset rheumatoid arthritis.
Terkeltaub R; Décary F; Esdaile J
J Rheumatol; 1984 Apr; 11(2):147-9. PubMed ID: 6610048
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of HLA-DR4 in the rheumatoid arthritis of a Chippewa band.
Harvey J; Arnett FC; Bias WB; Hsu SH; Stevens MB
J Rheumatol; 1981; 8(5):797-803. PubMed ID: 6975825
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies in early seropositive rheumatoid arthritis, before and during disease modifying antirheumatic drug treatment.
Paulus HE; Wiesner J; Bulpitt KJ; Patnaik M; Law J; Park GS; Wong WK
J Rheumatol; 2002 Dec; 29(12):2513-20. PubMed ID: 12465144
[TBL] [Abstract][Full Text] [Related]
15. Clinical and immunogenetic studies in multicase rheumatoid families.
Grennan DM; Dyer P; Dodds W; Read A; Haeney M; Clague R; Harris R
Q J Med; 1984; 53(212):479-85. PubMed ID: 6334866
[TBL] [Abstract][Full Text] [Related]
16. A systematic survey of HLA-A,B,C and D antigens and drug toxicity in rheumatoid arthritis.
Dequeker J; Van Wanghe P; Verdickt W
J Rheumatol; 1984 Jun; 11(3):282-6. PubMed ID: 6376799
[TBL] [Abstract][Full Text] [Related]
17. HLA-DRB1 genotype influences risk for and severity of rheumatoid arthritis.
Meyer JM; Evans TI; Small RE; Redford TW; Han J; Singh R; Moxley G
J Rheumatol; 1999 May; 26(5):1024-34. PubMed ID: 10332964
[TBL] [Abstract][Full Text] [Related]
18. Autoimmunity to native type II collagen--a distinct genetic subset of rheumatoid arthritis.
Klimiuk PS; Clague RB; Grennan DM; Dyer PA; Smeaton I; Harris R
J Rheumatol; 1985 Oct; 12(5):865-70. PubMed ID: 3878877
[TBL] [Abstract][Full Text] [Related]
19. [Associations of HLA-DR 4, DR 2, DRw 9 with clinical findings in rheumatoid arthritis].
Watanabe I; Taneichi K; Shibaki H
Ryumachi; 1989 Feb; 29(1):39-44. PubMed ID: 2787056
[TBL] [Abstract][Full Text] [Related]
20. A comparison of clinical and immunogenetic features in familial and sporadic rheumatoid arthritis.
Sanders PA; Grennan DM; Dyer PA; Thomson W; deLange GG
J Rheumatol; 1987 Aug; 14(4):718-22. PubMed ID: 3499510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
